ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 910.31 Million USD | 3.12% |
| 2022 | 882.8 Million USD | -3.99% |
| 2021 | 919.5 Million USD | 13.83% |
| 2020 | 807.8 Million USD | -5.93% |
| 2019 | 858.7 Million USD | 33.23% |
| 2018 | 644.53 Million USD | -6.55% |
| 2017 | 689.7 Million USD | 10.01% |
| 2016 | 626.93 Million USD | 9.68% |
| 2015 | 571.59 Million USD | -17.0% |
| 2014 | 688.7 Million USD | 8.05% |
| 2013 | 637.4 Million USD | -2.92% |
| 2012 | 656.6 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 240.55 Million USD | 0.0% |
| 2024 Q1 | 240.55 Million USD | -45.69% |
| 2023 Q4 | 442.95 Million USD | 83.61% |
| 2023 FY | 910.31 Million USD | 3.12% |
| 2023 Q1 | 244.45 Million USD | -44.27% |
| 2023 Q2 | 465.65 Million USD | 90.49% |
| 2023 Q3 | 241.25 Million USD | -48.19% |
| 2022 FY | 882.8 Million USD | -3.99% |
| 2022 Q4 | 438.63 Million USD | 76.37% |
| 2022 Q3 | 248.7 Million USD | -39.1% |
| 2022 Q2 | 408.35 Million USD | 65.16% |
| 2022 Q1 | 247.25 Million USD | -47.98% |
| 2021 Q2 | 402.27 Million USD | 89.93% |
| 2021 FY | 919.5 Million USD | 13.83% |
| 2021 Q1 | 211.8 Million USD | -49.9% |
| 2021 Q3 | 256.75 Million USD | -36.18% |
| 2021 Q4 | 475.29 Million USD | 85.12% |
| 2020 FY | 807.8 Million USD | -5.93% |
| 2020 Q2 | 355.98 Million USD | 85.5% |
| 2020 Q3 | 209.7 Million USD | -41.09% |
| 2020 Q4 | 422.72 Million USD | 101.59% |
| 2020 Q1 | 191.9 Million USD | -49.95% |
| 2019 Q1 | 182.89 Million USD | 2.93% |
| 2019 FY | 858.7 Million USD | 33.23% |
| 2019 Q4 | 383.38 Million USD | 48.89% |
| 2019 Q3 | 257.5 Million USD | -26.41% |
| 2019 Q2 | 349.93 Million USD | 91.32% |
| 2018 Q2 | 180.75 Million USD | 0.0% |
| 2018 Q1 | 180.75 Million USD | -0.25% |
| 2018 FY | 644.53 Million USD | -6.55% |
| 2018 Q4 | 177.7 Million USD | 0.0% |
| 2018 Q3 | 177.7 Million USD | -1.69% |
| 2017 Q3 | 181.2 Million USD | 0.03% |
| 2017 Q2 | 181.14 Million USD | 0.0% |
| 2017 Q1 | 181.14 Million USD | -19.56% |
| 2017 Q4 | 181.2 Million USD | 0.0% |
| 2017 FY | 689.7 Million USD | 10.01% |
| 2016 Q3 | 225.2 Million USD | 11.15% |
| 2016 Q1 | 132.1 Million USD | -32.53% |
| 2016 Q4 | 225.2 Million USD | 0.0% |
| 2016 Q2 | 202.6 Million USD | 53.37% |
| 2016 FY | 626.93 Million USD | 9.68% |
| 2015 FY | 571.59 Million USD | -17.0% |
| 2015 Q4 | 195.8 Million USD | 44.61% |
| 2015 Q3 | 135.4 Million USD | -25.19% |
| 2015 Q2 | 181 Million USD | 3.61% |
| 2015 Q1 | 174.7 Million USD | -24.14% |
| 2014 Q1 | 163.39 Million USD | -13.22% |
| 2014 FY | 688.7 Million USD | 8.05% |
| 2014 Q2 | 170.1 Million USD | 4.1% |
| 2014 Q4 | 230.3 Million USD | 45.3% |
| 2014 Q3 | 158.5 Million USD | -6.82% |
| 2013 Q3 | 161.8 Million USD | 4.32% |
| 2013 Q2 | 155.1 Million USD | 14.72% |
| 2013 FY | 637.4 Million USD | -2.92% |
| 2013 Q4 | 188.3 Million USD | 16.38% |
| 2013 Q1 | 135.2 Million USD | -17.21% |
| 2012 Q4 | 163.3 Million USD | 1.49% |
| 2012 Q3 | 160.89 Million USD | 0.0% |
| 2012 FY | 656.6 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -31692.239% |
| Ansell Limited | 495.5 Million USD | -83.717% |
| Ansell Limited | 495.5 Million USD | -83.717% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -999.365% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -52496.425% |
| Psykey, Inc. | 1.21 Million USD | -74916.957% |
| ConvaTec Group Plc | 872.5 Million USD | -4.334% |
| Encision Inc. | 3.77 Million USD | -24003.183% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -641821.835% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -827979.226% |
| Innovative MedTech Inc. | 6.09 Million USD | -14825.654% |
| LifePoint, Inc. | 7.42 Million USD | -12162.011% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -14237.939% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -106369.681% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -125264.709% |
| Reflect Scientific, Inc. | 1.06 Million USD | -85480.204% |
| SmileDirectClub, Inc. | 517 Million USD | -76.076% |
| Sector 10, Inc. | 39.84 Thousand USD | -2284599.764% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 86.297% |
| SheerVision, Inc. | 2.33 Million USD | -38941.95% |
| United Health Products, Inc. | 2.42 Million USD | -37414.986% |
| Vasamed, Inc. | 4.67 Million USD | -19380.688% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -35434.169% |
| Yubo International Biotech Limited | 1.25 Million USD | -72269.335% |